Your institution may have access to this item. Find your institution then sign in to continue.
Title
An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a standard treatment option. Preface.
Authors
Johnson AP; Leibovici L
Publication
The Journal of antimicrobial chemotherapy, 2013, Vol 68 Suppl 2, pii1